GE HealthCare Technologies Inc. (NASDAQ:GEHC) Plans $0.04 Quarterly Dividend

GE HealthCare Technologies Inc. (NASDAQ:GEHC) announced a quarterly dividend on Thursday, March 27th, RTT News reports. Shareholders of record on Friday, April 25th will be paid a dividend of 0.035 per share on Thursday, May 15th. This represents a $0.14 dividend on an annualized basis and a yield of 0.17%.

GE HealthCare Technologies has a dividend payout ratio of 2.7% indicating that its dividend is sufficiently covered by earnings. Analysts expect GE HealthCare Technologies to earn $5.20 per share next year, which means the company should continue to be able to cover its $0.14 annual dividend with an expected future payout ratio of 2.7%.

GE HealthCare Technologies Stock Performance

NASDAQ:GEHC opened at $81.66 on Friday. The company has a debt-to-equity ratio of 0.88, a quick ratio of 0.83 and a current ratio of 1.04. The stock has a 50-day simple moving average of $86.79 and a two-hundred day simple moving average of $85.90. The firm has a market capitalization of $37.34 billion, a PE ratio of 18.86, a P/E/G ratio of 3.19 and a beta of 1.13. GE HealthCare Technologies has a 52-week low of $74.51 and a 52-week high of $94.80.

GE HealthCare Technologies (NASDAQ:GEHC) last announced its quarterly earnings data on Thursday, February 13th. The company reported $1.45 EPS for the quarter, beating the consensus estimate of $1.26 by $0.19. GE HealthCare Technologies had a net margin of 10.13% and a return on equity of 25.74%. The firm had revenue of $5.32 billion for the quarter, compared to the consensus estimate of $5.33 billion. Analysts forecast that GE HealthCare Technologies will post 4.68 EPS for the current year.

Analyst Upgrades and Downgrades

A number of equities research analysts have issued reports on GEHC shares. Wells Fargo & Company increased their price objective on shares of GE HealthCare Technologies from $96.00 to $103.00 and gave the company an “overweight” rating in a report on Friday, February 14th. Citigroup boosted their price target on shares of GE HealthCare Technologies from $103.00 to $110.00 and gave the stock a “buy” rating in a research note on Thursday, February 13th. The Goldman Sachs Group upgraded GE HealthCare Technologies from a “neutral” rating to a “buy” rating and raised their price objective for the company from $85.00 to $100.00 in a research report on Tuesday, March 11th. Finally, Jefferies Financial Group upgraded GE HealthCare Technologies from a “hold” rating to a “buy” rating and boosted their target price for the stock from $95.00 to $103.00 in a research report on Wednesday, January 8th. One investment analyst has rated the stock with a sell rating, two have given a hold rating, nine have given a buy rating and one has given a strong buy rating to the company. According to data from MarketBeat, GE HealthCare Technologies has a consensus rating of “Moderate Buy” and a consensus price target of $98.75.

GE HealthCare Technologies Company Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.